ARQ 197
Phase 2Completed 1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Non-small-cell Lung Cancer
Conditions
Non-small-cell Lung Cancer
Trial Timeline
May 1, 2012 → Apr 1, 2015
NCT ID
NCT01580735About ARQ 197
ARQ 197 is a phase 2 stage product being developed by Kyowa Kirin for Non-small-cell Lung Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT01580735. Target conditions include Non-small-cell Lung Cancer.
What happened to similar drugs?
7 of 20 similar drugs in Non-small-cell Lung Cancer were approved
Approved (7) Terminated (6) Active (9)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01656265 | Phase 1 | Completed |
| NCT01580735 | Phase 2 | Completed |
| NCT01152645 | Phase 2 | Completed |
Competing Products
20 competing products in Non-small-cell Lung Cancer